Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

9.11

+0.02 (0.22%)

At close: Mar 28, 2025, 4:00 PM

9.00

-0.11 (-1.21%)

After-hours: Mar 28, 2025, 7:54 PM EDT

Gyre Therapeutics Market Cap

Gyre Therapeutics has a market cap or net worth of $852.81 million as of March 28, 2025. Its market cap has increased by 1,672.99% in one year.

Market Cap

852.81M

Enterprise Value

827.74M

1-Year Change

1,672.99%

Ranking

#2517

Market Cap Chart

Since April 12, 2006, Gyre Therapeutics's market cap has increased from $165.40M to $852.81M, an increase of 415.60%. That is a compound annual growth rate of 9.03%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	852.80M	-24.64%
Dec 31, 2024	1.13B	1,640.92%
Dec 29, 2023	65.00M	291.57%
Dec 30, 2022	16.60M	-42.16%
Dec 31, 2021	28.70M	-79.41%
Dec 31, 2020	139.40M	70.00%
Dec 31, 2019	82.00M	-12.95%
Dec 31, 2018	94.20M	60.20%
Dec 29, 2017	58.80M	653.85%
Dec 30, 2016	7.80M	-78.21%
Dec 31, 2015	35.80M	-60.31%
Dec 31, 2014	90.20M	-35.43%
Dec 31, 2013	139.70M	-5.10%
Dec 31, 2012	147.20M	-20.82%
Dec 30, 2011	185.90M	-75.52%
Dec 31, 2010	759.30M	31.14%
Dec 31, 2009	579.00M	551.29%
Dec 31, 2008	88.90M	-49.97%
Dec 31, 2007	177.70M	2.72%
Dec 29, 2006	173.00M	4.59%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	738.61B
UnitedHealth Group	472.03B
Johnson & Johnson	394.52B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	225.40B

Market Cap Rankings